Cormedix (CRMD) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD82,714.36+0.18%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Cormedix Inc (CRMD) Stock Price, Quote, News & History

CRMDNASDAQ

Trade with Public

Trade with Public

$7.38

0.060.82%

Last update: Oct 9, 7:10 PM

$7.42

0.11.37%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$7.32

Close

$7.38

Volume / Avg.

1.26M / 1.06M

Day Range

$7.42 - $7.42

52 Wk Range

6.13 - 13.02

Market Cap

$570.55M

P/E Ratio

3.36

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

21.07%

Days to Cover

18.49

Recent CorMedix Inc. News

CorMedix Stock Jumps on Strong DefenCath Sales

CorMedix Q2 earnings beat estimates as sales more than doubled, DefenCath revenue grew, and the company reaffirmed 2026 sales guidance.

Vandana Singh

Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday

Nasdaq Composite gained 200 points on Thursday, while Accelerant Holdings (NYSE: ARX) rose 44.2% after being acquired by Thoma Bravo and reporting strong Q2 results. Other top gainers include Omeros Corp (NASDAQ: OMER), CorMedix Inc (NASDAQ: CRMD), and Hyliion Holdings Corp (NYSE: HYLN).

Avi Kapoor

Frequency Electronics Posts Weak Q4 Results, Joins AST SpaceMobile And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

US stock futures mixed, Dow futures up 0.2%. Frequency Electronics (FEIM) shares down 8.3% after reporting Q4 losses. Other stocks also lower in pre-market.

Avi Kapoor

Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

US stock futures lower as Dow falls 100 points. Nike shares down 4% after Q4 results. Shutterstock, Optimum Communications, Cronos, and others also drop.

Avi Kapoor

CorMedix Stock Jumps As DefenCath Fuels Q1 Beat, 2026 Outlook Raised

CorMedix raises 2026 guidance after Q1 revenue surges on strong DefenCath demand and higher profitability.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

253.94M

Investing Cash Flow (TTM)

-285.62M

Financing Cash Flow (TTM)

129.95M

Free Cash Flow (TTM)

250.42M

Capital Expenditure (TTM)

-3.52M

Net Change in Cash (TTM)

98.27M

Analyst Trends and Forecast

4

Apr

1

Jul

1

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$464.47M

PE Ratio (TTM)

3.36

PE Ratio (FWD)

52.36

PEG Ratio (TTM)

5.22

PS Ratio (TTM)

1.46

PB Ratio (TTM)

1.24

Earnings Yield % (TTM)

29.80%

Earnings Yield % (FWD)

1.91%

EV / EBITDA (TTM)

1.80

Price / EBITDA (TTM)

2.62

Price / Free Cash Flow (TTM)

2.67

Book Value / Share

$5.91

Company Debt

Total Debt

$145.15M

LT Debt

$145.15M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$256.69M

Debt to Equity

0.31

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-